# Clindamycin phosphate and benzoyl peroxide

NDC: 0591-3916
Generic name: Clindamycin phosphate and benzoyl peroxide
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20190219
Marketing ended: 20260630
FDA application: ANDA205128

## Active ingredients

- BENZOYL PEROXIDE: 25 mg/g
- CLINDAMYCIN PHOSPHATE: 10 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0591-3916"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0591-3916
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87622142-000b-460b-977e-92d6735f5337